1100 related articles for article (PubMed ID: 12069609)
21. Structural requirements for conserved arginine of parathyroid hormone.
Barbier JR; MacLean S; Whitfield JF; Morley P; Willick GE
Biochemistry; 2001 Jul; 40(30):8955-61. PubMed ID: 11467957
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structural studies of new analogues of PTH(1-11) containing Cα-tetra-substituted amino acids in position 8.
Caporale A; Sturlese M; Schievano E; Mammi S; Peggion E
Amino Acids; 2010 Nov; 39(5):1369-79. PubMed ID: 20431900
[TBL] [Abstract][Full Text] [Related]
23. Residue 19 of the parathyroid hormone: structural consequences.
Piserchio A; Shimizu N; Gardella TJ; Mierke DF
Biochemistry; 2002 Nov; 41(44):13217-23. PubMed ID: 12403623
[TBL] [Abstract][Full Text] [Related]
24. Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking.
Gensure RC; Gardella TJ; Jüppner H
J Biol Chem; 2001 Aug; 276(31):28650-8. PubMed ID: 11356832
[TBL] [Abstract][Full Text] [Related]
25. Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains.
Carpenter KA; Schmidt R; von Mentzer B; Haglund U; Roberts E; Walpole C
Biochemistry; 2001 Jul; 40(28):8317-25. PubMed ID: 11444978
[TBL] [Abstract][Full Text] [Related]
26. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
Bisello A; Nakamoto C; Rosenblatt M; Chorev M
Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007
[TBL] [Abstract][Full Text] [Related]
27. Mono- and bicyclic analogs of parathyroid hormone-related protein. 2. Conformational analysis of antagonists by CD, NMR, and distance geometry calculations.
Maretto S; Mammi S; Bissacco E; Peggion E; Bisello A; Rosenblatt M; Chorev M; Mierke DF
Biochemistry; 1997 Mar; 36(11):3300-7. PubMed ID: 9116008
[TBL] [Abstract][Full Text] [Related]
28. Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone.
Chen Z; Xu P; Barbier JR; Willick G; Ni F
Biochemistry; 2000 Oct; 39(42):12766-77. PubMed ID: 11041841
[TBL] [Abstract][Full Text] [Related]
29. Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions.
Shimizu M; Carter PH; Khatri A; Potts JT; Gardella TJ
Endocrinology; 2001 Jul; 142(7):3068-74. PubMed ID: 11416029
[TBL] [Abstract][Full Text] [Related]
30. Design, conformational studies and analysis of structure-function relationships of PTH (1-11) analogues: the essential role of Val in position 2.
Caporale A; Gesiot L; Sturlese M; Wittelsberger A; Mammi S; Peggion E
Amino Acids; 2012 Jul; 43(1):207-18. PubMed ID: 21918876
[TBL] [Abstract][Full Text] [Related]
31. Conformational studies of mono- and bicyclic parathyroid hormone-related protein-derived agonists.
Mierke DF; Maretto S; Schievano E; DeLuca D; Bisello A; Mammi S; Rosenblatt M; Peggion E; Chorev M
Biochemistry; 1997 Aug; 36(34):10372-83. PubMed ID: 9265617
[TBL] [Abstract][Full Text] [Related]
32. Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3.
Shimizu N; Dean T; Khatri A; Gardella TJ
J Bone Miner Res; 2004 Dec; 19(12):2078-86. PubMed ID: 15537452
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
Hoare SR; Usdin TB
Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand.
Gardella TJ; Luck MD; Wilson AK; Keutmann HT; Nussbaum SR; Potts JT; Kronenberg HM
J Biol Chem; 1995 Mar; 270(12):6584-8. PubMed ID: 7896796
[TBL] [Abstract][Full Text] [Related]
35. Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor.
Dean T; Khatri A; Potetinova Z; Willick GE; Gardella TJ
J Biol Chem; 2006 Oct; 281(43):32485-95. PubMed ID: 16923805
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of parathyroid hormone related protein (residues 1-34) containing an Ala substituted for an Ile in position 15 (PTHrP[Ala15]-(1-34)).
Barden JA; Cuthbertson RM; Jia-Zhen W; Moseley JM; Kemp BE
J Biol Chem; 1997 Nov; 272(47):29572-8. PubMed ID: 9368020
[TBL] [Abstract][Full Text] [Related]
37. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
Hoare SR; Usdin TB
J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
[TBL] [Abstract][Full Text] [Related]
38. The glycine residue in cyclic lactam analogues of galanin(1-16)-NH2 is important for stabilizing an N-terminal helix.
Carpenter KA; Schmidt R; Yue SY; Hodzic L; Pou C; Payza K; Godbout C; Brown W; Roberts E
Biochemistry; 1999 Nov; 38(46):15295-304. PubMed ID: 10563815
[TBL] [Abstract][Full Text] [Related]
39. Functional properties of a synthetic chicken parathyroid hormone-related protein 1-36 fragment.
Schermer DT; Bradley MS; Bambino TH; Nissenson RA; Strewler GJ
J Bone Miner Res; 1994 Jul; 9(7):1041-6. PubMed ID: 7942150
[TBL] [Abstract][Full Text] [Related]
40. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
